Expression, Purification and Characterization of Functional Teduglutide Using GST Fusion System in Prokaryotic Cells
Purpose: Teduglutide is the first and only FDA-approved drug for long-term treatment of short bowel syndrome (SBS). The current study aimed to present an approach for production of teduglutide using recombinant DNA technology. Methods: The coding gene for teduglutide was cloned into pGEX-2T vector,...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Tabriz University of Medical Sciences,
2023-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|